AI Article Synopsis

  • The study investigates whether a liberal or restrictive blood transfusion strategy is more effective in reducing all-cause mortality in patients with anemia due to acute myocardial infarction (AMI).
  • Through a meta-analysis of three randomized controlled trials involving over 4,200 participants, it found no significant differences in mortality or other major health outcomes after 30 days between the two transfusion approaches.
  • The variability in blood transfusion use among patients receiving a restrictive strategy may account for the differing results across the trials, suggesting that individual treatment plans might need to be tailored based on patient needs.

Article Abstract

Background: The optimal transfusion strategy in acute myocardial infarction (AMI)-associated anemia remains uncertain.

Objectives: To compare all-cause mortality between liberal versus restrictive transfusion strategies in patients with AMI-associated anemia, using a meta-analytic approach.

Methods: Pubmed, Embase, and ClinicalTrials.gov were systematically searched for randomized controlled trials (RCTs) comparing liberal and restrictive transfusion strategies in AMI-associated anemia. Random-effects meta-analysis and trial sequential analysis (TSA) were conducted to compare blood use, efficacy, and safety endpoints. The p-values were 2-sided with an α of 0.05.

Results: In a pooled analysis involving 4,217 participants from three RCTs followed-up for 30 days, no statistically significant differences emerged between restrictive and liberal strategies in all-cause mortality (RR 1.03; 95% CI 0.67-1.57; p=0.90) and other efficacy endpoints (recurrent AMI, unscheduled revascularization, acute heart failure, stroke, and acute kidney injury), as well as in safety endpoints including allergic reactions, infection, and acute lung injury. TSA did not reach futility boundaries. In patients assigned to restrictive strategy, substantial differences in transfusion use were observed across RCTs, correlating with mortality rates, and likely accounting for between-study heterogeneity in treatment effects.

Conclusions: In patients with AMI-associated anemia, there is no clear superiority between liberal and restrictive transfusion strategies in all-cause mortality or other major outcomes in 30 days. However, the heterogeneity observed in blood use between the restrictive groups likely explains variable findings across RCTs.

Download full-text PDF

Source
http://dx.doi.org/10.36660/abc.20240158DOI Listing

Publication Analysis

Top Keywords

transfusion strategies
16
ami-associated anemia
16
all-cause mortality
12
restrictive transfusion
12
acute myocardial
8
myocardial infarction
8
meta-analysis trial
8
trial sequential
8
sequential analysis
8
patients ami-associated
8

Similar Publications

Introduction: Acute myocardial infarction (AMI) poses a significant global health burden, warranting meticulous management strategies, particularly in patients with concurrent anemia. Blood transfusion strategies play a pivotal role in optimizing oxygen delivery while minimizing transfusion-related risks. Two contrasting approaches, liberal and restrictive transfusion strategies, have emerged, yet their comparative effectiveness remains uncertain due to conflicting evidence.

View Article and Find Full Text PDF

Risk analyses for perioperative morbidities after aseptic knee revision arthroplasty.

Arch Orthop Trauma Surg

December 2024

Department of General Orthopaedics, Auguste-Viktoria-Clinic Bad Oeynhausen, University Hospital of RUB-Bochum, Am Kokturkanal, 32545, Bad Oeynhausen, Germany.

Introduction: Total lower limb arthroplasties are standard orthopedic surgeries that are steadily increasing in modern civilization. In proportion, the number of revision arthroplasties and the corresponding financial burden for healthcare systems will increase. The present clinical investigation analyzed morbidities after aseptic revision knee arthroplasty.

View Article and Find Full Text PDF

Background: Radiation-induced heart disease (RIHD) is one of the most serious complications of radiation therapy (RT) for thoracic tumors, and new interventions are needed for its prevention and treatment. Small extracellular vesicles (sEVs) from stem cells have attracted much attention due to their ability to repair injury. However, the role of umbilical cord mesenchymal stem cell (UCMSC)-derived sEVs in protecting cardiac organoids from radiation-induced injury and the underlying mechanisms are largely unknown.

View Article and Find Full Text PDF

Patient Blood Management: A conceptual and analytical vision from the leadership in Spain.

Rev Esp Anestesiol Reanim (Engl Ed)

December 2024

Servicio de Anestesiología y Reanimación, Hospital Universitario Bellvitge. Barcelona, Spain; Grupo de trabajo en Patient Blood Management de la Sociedad Española de Anestesiología y Reanimación (SEDAR), Madrid, Spain.

The evolution of blood saving programs to Patient Blood Management (PBM) represents a broader and more comprehensive approach to optimize the use of the patient's own blood, thus improving clinical outcomes and minimizing the risks associated with allogeneic blood transfusion with a holistic view of socio-economic sustainability. Implementing the strategies of the three PBM pillars in any hospital center involves a transversal change throughout the organization in which it can be very useful to apply the strategy defined by Kotter at the business level for change management. The support of renowned institutions such as the World Health Organization and the European Commission demonstrates the importance and urgency of implementing PBM programs, setting guidelines at an international level and supporting the adoption of effective strategies in the management of blood transfusion at a national and institutional level.

View Article and Find Full Text PDF

Raman Spectral Feature Enhancement Framework for Complex Multiclassification Tasks.

Anal Chem

December 2024

State Key Laboratory of Optical Fiber and Cable Manufacture Technology, Guangdong Key Laboratory of Integrated Optoelectronics Intellisense, Department of EEE, Southern University of Science and Technology, Shenzhen 518055, China.

Raman spectroscopy enables label-free clinical diagnosis in a single step. However, identifying an individual carrying a specific disease from people with a multi-disease background is challenging. To address this, we developed a Raman spectral implicit feature augmentation with a Raman Intersection, Union, and Subtraction augmentation strategy (RIUS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!